[Evidence of Gastric Cancer Surgery Established from the Clinical Trials of Japanese Clinical Oncology Group].
So far, JCOG Stomach Cancer Study Group had conducted phase III study to confirm efficacy of para-aortic nodaldissection( PAND), left thoraco-abdominalapproach for gastric cancer invading esophagus, spleen-preserving surgery, bursectomy, and laparoscopic surgery. JCOG9501 demonstrated that efficacy of PAND was denied but D2 was highly safe surgery. JCOG9502 showed that efficacy of thoraco-abdominalapproach was denied and transhiatalapproach was a standard procedure. JCOG0110 clearly confirmed non-inferiority of spleen-preserving surgery against splenectomy. JCOG1001 showed that efficacy of bursectomy was denied and non-bursectomy was a standard. JCOG0912 would prove non-inferiority of laparoscopic distalgastrectomy for Stage I gastric cancer.